Tam CS - Search Results

1

Final analysis from RESONATE: Up to six years of follow-up on ibrutinib in patients with previously treated chronic lymphocytic leukemia or small lymphocytic lymphoma.

Munir T, Brown JR, O'Brien S, Barrientos JC, Barr PM, Reddy NM, Coutre S, Tam CS, Mulligan SP, Jaeger U, Kipps TJ, Moreno C, Montillo M, Burger JA, Byrd JC, Hillmen P, Dai S, Szoke A, Dean JP, Woyach JA. Munir T, et al. Among authors: tam cs. Am J Hematol. 2019 Dec;94(12):1353-1363. doi: 10.1002/ajh.25638. Epub 2019 Oct 13. Am J Hematol. 2019. PMID: 31512258 Free PMC article. Clinical Trial.

2

Reversible posterior leukoencephalopathy syndrome complicating cytotoxic chemotherapy for hematologic malignancies.

Tam CS, Galanos J, Seymour JF, Pitman AG, Stark RJ, Prince HM. Tam CS, et al. Am J Hematol. 2004 Sep;77(1):72-6. doi: 10.1002/ajh.20147. Am J Hematol. 2004. PMID: 15307110 Free article.

3

Fludarabine, cyclophosphamide, and rituximab for the treatment of patients with chronic lymphocytic leukemia or indolent non-Hodgkin lymphoma.

Tam CS, Wolf M, Prince HM, Januszewicz EH, Westerman D, Lin KI, Carney D, Seymour JF. Tam CS, et al. Cancer. 2006 Jun 1;106(11):2412-20. doi: 10.1002/cncr.21882. Cancer. 2006. PMID: 16649223 Free article.

4

Systemic mastocytosis in association with chronic lymphocytic leukemia: a rare diagnosis.

Ault P, Lynn A, Tam CS, Medeiros LJ, Keating MJ. Ault P, et al. Among authors: tam cs. Leuk Res. 2007 Dec;31(12):1755-8. doi: 10.1016/j.leukres.2007.04.002. Epub 2007 May 22. Leuk Res. 2007. PMID: 17521719

5

Chemoimmunotherapy of chronic lymphocytic leukemia.

Tam CS, Keating MJ. Tam CS, et al. Best Pract Res Clin Haematol. 2007 Sep;20(3):479-98. doi: 10.1016/j.beha.2007.02.004. Best Pract Res Clin Haematol. 2007. PMID: 17707835 Review.

6

The natural history of fludarabine-refractory chronic lymphocytic leukemia patients who fail alemtuzumab or have bulky lymphadenopathy.

Tam CS, O'Brien S, Lerner S, Khouri I, Ferrajoli A, Faderl S, Browning M, Tsimberidou AM, Kantarjian H, Wierda WG. Tam CS, et al. Leuk Lymphoma. 2007 Oct;48(10):1931-9. doi: 10.1080/10428190701573257. Leuk Lymphoma. 2007. PMID: 17917961

7

Phase I trial of nelarabine in indolent leukemias.

Gandhi V, Tam C, O'Brien S, Jewell RC, Rodriguez CO Jr, Lerner S, Plunkett W, Keating MJ. Gandhi V, et al. J Clin Oncol. 2008 Mar 1;26(7):1098-105. doi: 10.1200/JCO.2007.14.1986. J Clin Oncol. 2008. PMID: 18309944 Clinical Trial.

8

Chronic lymphocytic leukaemia CD20 expression is dependent on the genetic subtype: a study of quantitative flow cytometry and fluorescent in-situ hybridization in 510 patients.

Tam CS, Otero-Palacios J, Abruzzo LV, Jorgensen JL, Ferrajoli A, Wierda WG, Lerner S, O'Brien S, Keating MJ. Tam CS, et al. Br J Haematol. 2008 Apr;141(1):36-40. doi: 10.1111/j.1365-2141.2008.07012.x. Br J Haematol. 2008. PMID: 18324964 Free article.

9

Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia.

Tam CS, O'Brien S, Wierda W, Kantarjian H, Wen S, Do KA, Thomas DA, Cortes J, Lerner S, Keating MJ. Tam CS, et al. Blood. 2008 Aug 15;112(4):975-80. doi: 10.1182/blood-2008-02-140582. Epub 2008 Apr 14. Blood. 2008. PMID: 18411418 Free PMC article. Clinical Trial.

10

Failure to achieve a major cytogenetic response by 12 months defines inadequate response in patients receiving nilotinib or dasatinib as second or subsequent line therapy for chronic myeloid leukemia.

Tam CS, Kantarjian H, Garcia-Manero G, Borthakur G, O'Brien S, Ravandi F, Shan J, Cortes J. Tam CS, et al. Blood. 2008 Aug 1;112(3):516-8. doi: 10.1182/blood-2008-02-141580. Epub 2008 May 20. Blood. 2008. PMID: 18492956 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

326 results

Search Page